Inventor
RAJPAL ARVIND
US45 patents
⚠️ This page may combine multiple inventors who share the name “RAJPAL ARVIND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
13 patentsUS9969809B2May 15, 2018
Therapeutic antibodies and their uses
PFIZER44 citations96
US10294304B2May 21, 2019
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER16 citations93
US11814435B2Nov 14, 2023
Therapeutic antibodies and their uses
PFIZER5 citations84
US10793635B2Oct 6, 2020
Therapeutic antibodies and their uses
PFIZER4 citations83
US10040860B2Aug 7, 2018
Therapeutic antibodies and their uses
PFIZER6 citations83
US11155630B2Oct 26, 2021
Therapeutic antibodies and their uses
PFIZER3 citations72
US10196452B2Feb 5, 2019
Binding molecules to the human OX40 receptor
PFIZER1 citations72
US11312782B2Apr 26, 2022
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER1 citations71
US10941216B2Mar 9, 2021
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
PFIZER0 citations62
US11912776B2Feb 27, 2024
Chimeric antigen receptors targeting B-cell maturation antigen
PFIZER0 citations61
US8846037B2Sep 30, 2014
Antibodies to IL-6 and their uses
PFIZER0 citations52
US9840562B2Dec 12, 2017
Binding molecules to the human OX40 receptor
PFIZER0 citations51
US9238691B2Jan 19, 2016
Nucleic acids encoding antibodies to CCR2
PFIZER1 citations50
RINAT NEUROSCIENCE CORP
10 patentsUS8871908B2Oct 28, 2014
Antibodies specific for Trop-2 and their uses
RINAT NEUROSCIENCE CORP86 citations96
US10155037B2Dec 18, 2018
Anti-PD-1 antibodies and methods of use thereof
RINAT NEUROSCIENCE CORP18 citations93
US10138303B2Nov 27, 2018
Heterodimeric proteins and methods for producing and purifying them
RINAT NEUROSCIENCE CORP14 citations92
US9399074B2Jul 26, 2016
Antibodies specific for trop-2 and their uses
RINAT NEUROSCIENCE CORP19 citations91
US10660953B2May 26, 2020
Anti-PD-1 antibodies and methods of use thereof
RINAT NEUROSCIENCE CORP2 citations71
US11602525B2Mar 14, 2023
Antibody-drug conjugates with high drug loading
RINAT NEUROSCIENCE CORP2 citations66
US11390689B2Jul 19, 2022
Heterodimeric proteins and methods for producing and purifying them
RINAT NEUROSCIENCE CORP1 citations62
US11338035B2May 24, 2022
Anti-PD-1 antibodies and methods of use thereof
RINAT NEUROSCIENCE CORP0 citations61
US11091544B2Aug 17, 2021
Antibodies specific for Trop-2 and their uses
RINAT NEUROSCIENCE CORP0 citations61
US10100114B2Oct 16, 2018
Antibodies specific for TROP-2 and their uses
RINAT NEUROSCIENCE CORP1 citations61
BRISTOL MYERS SQUIBB CO
6 patentsUS7960515B2Jun 14, 2011
Binding molecules to the human OX40 receptor
BRISTOL MYERS SQUIBB CO205 citations98
US10653791B2May 19, 2020
Antibodies comprising modified heavy constant regions
BRISTOL MYERS SQUIBB CO10 citations83
US11213586B2Jan 4, 2022
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR)
BRISTOL MYERS SQUIBB CO5 citations72
US11623965B2Apr 11, 2023
Prodruggable antibodies, prodrugs thereof, and methods of use and making
BRISTOL MYERS SQUIBB CO1 citations61
US12478674B2Nov 25, 2025
Ipilimumab variants with enhanced specificity for binding at low pH
BRISTOL MYERS SQUIBB CO1 citations59
US11306150B2Apr 19, 2022
Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonist
BRISTOL MYERS SQUIBB CO0 citations47
FIVE PRIME THERAPEUTICS INC
4 patentsUS12195535B2Jan 14, 2025
Antibodies binding to VISTA at acidic pH
FIVE PRIME THERAPEUTICS INC0 citations60
US11603406B2Mar 14, 2023
Antibodies binding to VISTA at acidic pH
FIVE PRIME THERAPEUTICS INC0 citations60
US12173069B2Dec 24, 2024
Antibodies binding to vista at acidic pH
FIVE PRIME THERAPEUTICS INC1 citations58
US12091462B2Sep 17, 2024
Antibodies binding to vista at acidic pH
FIVE PRIME THERAPEUTICS INC0 citations58